US 10519110
Heterocyclic compound
granted A61KA61K31/437A61K31/443
Quick answer
US patent 10519110 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/437, A61K31/443, A61K31/4433, A61K31/4436